Key result
Stem cell therapies for cardiovascular repair are being evaluated for their therapeutic readiness to address the high mortality and morbidity associated with ischemic heart disease.
Key points are not available for this paper at this time.
Ischemic heart disease is among the most frequent causes of death and morbidity worldwide [1]. Despite advances in available cardiovascular therapies, a significant percentage of patients still die...
No takes yet. Share an insight, caveat, or question.
Gara et al. (2017) studied this question. Stem cell therapies for cardiovascular repair are being evaluated for their therapeutic readiness to address the high mortality and morbidity associated with ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: